Article Text

other Versions

PDF
Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation
  1. Juan Sanchis (sanchis_juafor{at}gva.es)
  1. Hospital Clínic Universitari. Universitat de València, Spain
    1. Xavier Bosch
    1. Hospital Clínic i Provincial. Barcelona, Spain
      1. Vicent Bodí
      1. Hospital Clínic Universitari. Universitat de València, Spain
        1. Nieves Bellera
        1. Hospital Clínic i Provincial. Barcelona, Spain
          1. Julio Núñez
          1. Hospital Clínic Universitari. Universitat de València, Spain
            1. Begoña Benito
            1. Hospital Clínic i Provincial. Barcelona, Spain
              1. Jordi Ordóñez
              1. Hospital Santa Creu i San Pau. Barcelona, Spain
                1. Luciano Consuegra
                1. Hospital Clínic Universitari. Universitat de València, Spain
                  1. Magda Heras
                  1. Hospital Clínic i Provincial. Barcelona, Spain
                    1. Àngel Llàcer
                    1. Hospital Clínic Universitari. Universitat de València, Spain

                      Abstract

                      Objective To investigate the combination of clinical data, exercise testing and biomarkers for evaluation of patients with chest pain without ST-segment deviation or troponin elevation.

                      Design Prospective cohort design

                      Settting Two teaching hospitals in Spain

                      Patients 422 patients presenting to the emergency department were studied. Leukocyte count, C-reactive protein (CRP), pregnancy-associated plasma protein-A (PAPP-A) and N-terminal pro-brain natriuretic peptide (NT-proBNP) were determined. A validated clinical risk score (number of points according to pain characteristics and risk factors) was used for clinical evaluation and early exercise testing was performed.

                      Main outcome measures Adverse events (death, myocardial infarction or revascularization) during a median 60 weeks follow-up.

                      Results By ROC curve analysis, the association between death or myocardial infarction and adverse events was not significant with leukocyte count (p=0.3, p=0.3) or CRP (p=0.5, p=0.8), border-line significant with PAPP-A (p=0.07, p=0.04) and strongly significant with NT-pro-BNP (p=0.0001, p=0.0001). By Cox regression including clinical risk score, exercise testing result and biomarkers, exercise testing was the independent predictor of revascularization (p=0.0001), whereas risk score (p=0.03) and NT-proBNP (p=0.0004) predicted death or myocardial infarction. Inclusion of NT-proBNP improved the accuracy of the model for death or myocardial infarction (C-statistic 0.84 vs 0.76, p=0.01). The combination of clinical score and NT-proBNP afforded the stratification in high (17.2%, p=0.0001), intermediate (5.3%) and low (1.1%) risk categories of death or myocardial infarction.

                      Conclusions NT-proBNP provides incremental prognostic information above that given by clinical history and exercise testing in patients with chest pain without ST-segment deviation and negative troponin.

                      • Acute coronary syndromes
                      • Biomarkers
                      • Prognosis

                      Statistics from Altmetric.com

                      Request permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.